Published in Antioxid Redox Signal on September 01, 2009
Intracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeys. Cell Transplant (2013) 0.88
Parkinson's disease: from molecular pathways in disease to therapeutic approaches. Antioxid Redox Signal (2009) 0.83
Preclinical assessment of stem cell therapies for neurological diseases. ILAR J (2009) 0.81
Aged monkeys as a partial model for Parkinson's disease. Pharmacol Biochem Behav (2011) 0.78
Differentiation of rhesus adipose stem cells into dopaminergic neurons. Neural Regen Res (2012) 0.77
Pre- and postmortem imaging of transplanted cells. Int J Nanomedicine (2015) 0.76
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
Neurogenesis in the adult human hippocampus. Nat Med (1998) 17.53
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88
More hippocampal neurons in adult mice living in an enriched environment. Nature (1997) 10.06
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (1983) 9.41
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol (1965) 9.18
In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol (2001) 9.04
Feeder-independent culture of human embryonic stem cells. Nat Methods (2006) 7.61
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci U S A (2008) 7.52
Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A (2004) 7.51
Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc (2007) 7.01
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med (2008) 6.90
Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med (2008) 6.86
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science (1993) 6.73
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21
Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol (2000) 6.21
Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature (2004) 5.85
Retracted Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science (2005) 5.21
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
[Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system]. Klin Wochenschr (1960) 4.77
[The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia]. Wien Klin Wochenschr (1961) 4.63
Neurogenesis in the neocortex of adult primates. Science (1999) 4.57
Neurogenesis in the adult rat: electron microscopic analysis of light radioautographs. Science (1977) 4.34
Isolation of a primate embryonic stem cell line. Proc Natl Acad Sci U S A (1995) 3.85
Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med (1995) 3.64
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39
Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells (2005) 3.38
Identification of intrinsic determinants of midbrain dopamine neurons. Cell (2006) 3.31
Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science (1990) 3.31
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations. Am J Hum Genet (2005) 3.29
Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell (2008) 3.15
Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus. Neuroscience (1994) 3.10
A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet (2005) 3.09
Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med (2008) 2.80
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Research in motion: the enigma of Parkinson's disease pathology spread. Nat Rev Neurosci (2008) 2.51
Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin. Stem Cells (2006) 2.37
Functional recovery in parkinsonian monkeys treated with GDNF. Nature (1996) 2.35
Dopaminergic differentiation of human embryonic stem cells. Stem Cells (2004) 2.30
Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest (2005) 2.25
The Parkinson's complex: parkinsonism is just the tip of the iceberg. Ann Neurol (2006) 2.23
Human embryonic stem cell-derived dopaminergic neurons reverse functional deficit in parkinsonian rats. Stem Cells (2007) 2.22
Transplanted bone marrow generates new neurons in human brains. Proc Natl Acad Sci U S A (2003) 2.20
Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A (2007) 2.19
Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells (2004) 2.05
FDA regulation of stem-cell-based therapies. N Engl J Med (2006) 2.01
Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells (2004) 1.83
Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci (2002) 1.74
Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol Reprod (1996) 1.70
Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res (1979) 1.68
A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis (2004) 1.65
Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med (1987) 1.62
Predictors of deterioration in health-related quality of life in Parkinson's disease: results from the DATATOP trial. Mov Disord (2008) 1.59
Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med (1989) 1.59
Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Nat Rev Neurosci (2001) 1.57
Primate embryonic stem cells. Curr Top Dev Biol (1998) 1.56
Long-term survival of dopamine neurons derived from parthenogenetic primate embryonic stem cells (cyno-1) after transplantation. Stem Cells (2005) 1.56
Contributions of non-human primates to neuroscience research. Lancet (2008) 1.54
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann N Y Acad Sci (2003) 1.53
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease. Hum Mol Genet (2006) 1.48
The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. Histochemical and behavioral studies. J Neurosurg (1990) 1.48
Autotransplantation of human carotid body cell aggregates for treatment of Parkinson's disease. Neurosurgery (2003) 1.47
Therapeutic cloning in individual parkinsonian mice. Nat Med (2008) 1.46
Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells (2004) 1.44
Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates. Gene Ther (2006) 1.38
Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease. Exp Neurol (2007) 1.36
Current status of gene therapy trials for Parkinson's disease. Exp Neurol (2007) 1.34
Striatal volume differences between non-human and human primates. J Neurosci Methods (2008) 1.33
Estrogen is essential for maintaining nigrostriatal dopamine neurons in primates: implications for Parkinson's disease and memory. J Neurosci (2000) 1.30
Human cord blood-derived cells attain neuronal and glial features in vitro. J Cell Sci (2002) 1.29
No evidence for infection of human cells with porcine endogenous retrovirus (PERV) after exposure to porcine fetal neuronal cells. Transplantation (2000) 1.25
Cellular replacement therapy for Parkinson's disease--where we are today? Neuroscientist (2002) 1.25
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. Acta Neurol Scand Suppl (1984) 1.20
GDNF-secreting human neural progenitor cells increase tyrosine hydroxylase and VMAT2 expression in MPTP-treated cynomolgus monkeys. Cell Transplant (2008) 1.19
Crossroads in GDNF therapy for Parkinson's disease. Mov Disord (2006) 1.19
The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model. Stem Cells (2009) 1.17
A protocol for the differentiation of human embryonic stem cells into dopaminergic neurons using only chemically defined human additives: Studies in vitro and in vivo. Brain Res (2006) 1.17
Umbilical cord blood-derived stem cells and brain repair. Ann N Y Acad Sci (2005) 1.14
Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell Transplant (2000) 1.14
Deep brain stimulation for Parkinson's disease: prevalence of adverse events and need for standardized reporting. Mov Disord (2008) 1.13
New prospects for human stem-cell therapy in the nervous system. Trends Neurosci (1999) 1.13
In vitro generation and transplantation of precursor-derived human dopamine neurons. J Neurosci Res (2001) 1.09
Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain (1996) 1.09
Human neural stem cells migrate along the nigrostriatal pathway in a primate model of Parkinson's disease. Exp Neurol (2008) 1.08
Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias. Prog Brain Res (2008) 1.06
Increased survival and migration of engrafted mesenchymal bone marrow stem cells in 6-hydroxydopamine-lesioned rodents. Neurosci Lett (2005) 1.06
Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders. Neurogenetics (2008) 1.06
Parthenogenetic dopamine neurons from primate embryonic stem cells restore function in experimental Parkinson's disease. Brain (2008) 1.06
Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet (1986) 1.06
Neural precursors derived from embryonic stem cells, but not those from fetal ventral mesencephalon, maintain the potential to differentiate into dopaminergic neurons after expansion in vitro. Stem Cells (2006) 1.05
Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy (2008) 1.01
Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale. Mov Disord (1999) 1.00
Behavioral and morphological comparison of two nonhuman primate models of Huntington's disease. Neurosurgery (2002) 1.54
Contributions of non-human primates to neuroscience research. Lancet (2008) 1.54
Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells (2012) 1.28
The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflammation (2011) 1.19
Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes. Front Biosci (2003) 1.09
Chronic ischemic stroke model in cynomolgus monkeys: behavioral, neuroimaging and anatomical study. Neurol Res (2003) 1.09
Intraoperative intracerebral MRI-guided navigation for accurate targeting in nonhuman primates. Cell Transplant (2010) 1.04
Evaluation of hydrodynamic limb vein injections in nonhuman primates. Hum Gene Ther (2010) 0.98
Pathways of infusate loss during convection-enhanced delivery into the putamen nucleus. Stereotact Funct Neurosurg (2013) 0.96
Mood, memory and movement: an age-related neurodegenerative complex? Curr Aging Sci (2008) 0.93
Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration. Neurobiol Dis (2005) 0.92
Strategies for improving animal models for regenerative medicine. Cell Stem Cell (2013) 0.90
Survival and early differentiation of human neural stem cells transplanted in a nonhuman primate model of stroke. J Neurosurg (2006) 0.89
Blood vessels and parkinsonism. Front Biosci (2004) 0.86
Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. PLoS One (2012) 0.85
A monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeys. PLoS One (2012) 0.84
Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system. J Comp Neurol (2003) 0.83
Preclinical assessment of stem cell therapies for neurological diseases. ILAR J (2009) 0.81
Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys. Cell Transplant (2007) 0.80
Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR- γ Agonist against MPTP. PPAR Res (2013) 0.80
Can we prevent parkinson's disease? Front Biosci (Landmark Ed) (2009) 0.77
The effects of a selective dopamine D2 receptor agonist on behavioral and pathological outcome in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated squirrel monkeys. J Pharmacol Exp Ther (2005) 0.77
The immunophilin ligand GPI-1046 does not have neuroregenerative effects in MPTP-treated monkeys. Exp Neurol (2002) 0.76
The Relation between Catheter Occlusion and Backflow during Intraparenchymal Cerebral Infusions. Stereotact Funct Neurosurg (2015) 0.75
Real-Time Intraoperative MRI Intracerebral Delivery of Induced Pluripotent Stem Cell-Derived Neurons. Cell Transplant (2016) 0.75
Lentiviral Delivery of Glial Cell Line-derived Neurotrophic Factor in Aged 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated Rhesus Monkeys 883. Neurosurgery (2006) 0.75